These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. McTavish D; Benfield P Drugs; 1990 Jan; 39(1):136-53. PubMed ID: 2178909 [TBL] [Abstract][Full Text] [Related]
6. Clomipramine for panic disorder: I. The first 10 weeks of a long-term comparison with imipramine. Cassano GB; Petracca A; Perugi G; Nisita C; Musetti L; Mengali F; McNair DM J Affect Disord; 1988; 14(2):123-7. PubMed ID: 2966825 [TBL] [Abstract][Full Text] [Related]
8. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline. Den Boer JA; Westenberg HG Int Clin Psychopharmacol; 1988 Jan; 3(1):59-74. PubMed ID: 2833543 [TBL] [Abstract][Full Text] [Related]
10. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Ananth J; Pecknold JC; van den Steen N; Engelsmann F Prog Neuropsychopharmacol; 1981; 5(3):257-62. PubMed ID: 7022517 [No Abstract] [Full Text] [Related]
11. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review. Piccinelli M; Pini S; Bellantuono C; Wilkinson G Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913 [TBL] [Abstract][Full Text] [Related]
12. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients. Jenike MA; Baer L; Summergrad P; Weilburg JB; Holland A; Seymour R Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643 [TBL] [Abstract][Full Text] [Related]
13. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. Insel TR; Murphy DL; Cohen RM; Alterman I; Kilts C; Linnoila M Arch Gen Psychiatry; 1983 Jun; 40(6):605-12. PubMed ID: 6342562 [TBL] [Abstract][Full Text] [Related]
14. Clomipramine treatment for panic attacks in patients with mitral valve prolapse. Grunhaus L; Gloger S; Birmacher B J Clin Psychiatry; 1984 Jan; 45(1):25-7. PubMed ID: 6363396 [TBL] [Abstract][Full Text] [Related]
15. Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Broocks A; Bandelow B; Pekrun G; George A; Meyer T; Bartmann U; Hillmer-Vogel U; Rüther E Am J Psychiatry; 1998 May; 155(5):603-9. PubMed ID: 9585709 [TBL] [Abstract][Full Text] [Related]
16. Absence of placebo response in obsessive-compulsive disorder. Mavissakalian MR; Jones B; Olson S J Nerv Ment Dis; 1990 Apr; 178(4):268-70. PubMed ID: 2319236 [TBL] [Abstract][Full Text] [Related]
17. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients. Greist JH; Jefferson JW; Rosenfeld R; Gutzmann LD; March JS; Barklage NE J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006 [TBL] [Abstract][Full Text] [Related]
18. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment. Zohar J; Insel TR; Zohar-Kadouch RC; Hill JL; Murphy DL Arch Gen Psychiatry; 1988 Feb; 45(2):167-72. PubMed ID: 3276283 [TBL] [Abstract][Full Text] [Related]
19. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder. Pato MT; Pigott TA; Hill JL; Grover GN; Bernstein S; Murphy DL Am J Psychiatry; 1991 Jan; 148(1):127-9. PubMed ID: 1984696 [TBL] [Abstract][Full Text] [Related]